Source:http://linkedlifedata.com/resource/pubmed/id/12464780
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2002-12-4
|
pubmed:abstractText |
The aim of this study was to demonstrate that radionuclide sentinel node detection can be applied to patients with non-palpable breast cancer. One hundred and ten consecutive women with unilateral breast cancer were studied. Group 1 was made up of 80 patients with palpable breast cancer (mean age, 58 years) and group 2 of 30 patients with non-palpable breast cancer detected mammographically (mean age, 55 years). Tc-nanocolloid (111 MBq) was injected peritumorally in palpable tumours, and in the tumour area (ultrasound guided) in non-palpable tumours. At 2 h post-injection, anterior and lateral scintigrams were obtained from patients in the supine position. The location of the sentinel node was marked on the patient's skin. Patients with non-palpable tumours were moved to the surgery room 3 h later, and those with palpable tumours 24 h later. The histopathological study included three haematoxylineosin sections and immunochemistry. All patients underwent axillary lymphadenectomy. The sentinel node was detected in 67 cases (84%) in group 1 and in 28 cases (93%) in group 2. In four patients (5%) in group 1 and two patients (7%) in group 2, no axillary sentinel node was detected in the surgical bed, although it had been seen in scintigraphy. In nine patients (11%) in group 1, neither scintigraphic nor surgical detection was successful. Skip metastasis was seen in six cases (10%) of palpable tumours and in one case (4%) of non-palpable tumours. It can be concluded that non-palpable breast tumours cannot be considered an exclusion criterion for sentinel node localization and biopsy. Ultrasonography-guided injection, followed by scintigraphic and surgical detection of the sentinel node, may help in the management of patients with non-palpable breast tumours.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0143-3636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1165-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12464780-Adult,
pubmed-meshheading:12464780-Aged,
pubmed-meshheading:12464780-Aged, 80 and over,
pubmed-meshheading:12464780-Breast Neoplasms,
pubmed-meshheading:12464780-Female,
pubmed-meshheading:12464780-Gamma Cameras,
pubmed-meshheading:12464780-Humans,
pubmed-meshheading:12464780-Lymph Node Excision,
pubmed-meshheading:12464780-Lymph Nodes,
pubmed-meshheading:12464780-Middle Aged,
pubmed-meshheading:12464780-Radiopharmaceuticals,
pubmed-meshheading:12464780-Sentinel Lymph Node Biopsy,
pubmed-meshheading:12464780-Technetium Tc 99m Aggregated Albumin
|
pubmed:year |
2002
|
pubmed:articleTitle |
Sentinel node localization in patients with non-palpable breast cancer.
|
pubmed:affiliation |
S. Medicina Nuclear and Unidad Funcional de Mama, CSUB, Hospital de Bellvitge, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|